Helene Rey

Title: Helene Rey: Innovator in Depression Treatment

Introduction

Helene Rey is a prominent inventor based in Pratteln, Switzerland. She has made significant contributions to the field of mental health, particularly in the treatment of depression. With a total of five patents to her name, Rey is recognized for her innovative approaches to medication delivery and formulation.

Latest Patents

Among her latest patents is a method for the treatment of depression using oral dosage forms of ketamine. This invention relates to an oral dosage form for the administration of ketamine, designed for preferably once or twice daily use. Another notable patent involves hydroxynorketamine for use in the treatment of depression. This invention focuses on administering hydroxynorketamine in the form of at least one prodrug, which is delivered in a modified-release dosage form.

Career Highlights

Helene Rey has worked with several companies throughout her career, including Ketabon GmbH and Develco Pharma Schweiz AG. Her work in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in pharmaceutical treatments.

Collaborations

Some of her notable coworkers include Sascha Manthei and Marc Fischer. Their collaboration has likely played a role in the development of her groundbreaking patents.

Conclusion

Helene Rey's contributions to the treatment of depression through innovative pharmaceutical methods highlight her importance in the field of mental health. Her patents reflect a commitment to improving patient care and advancing medical science.